Brief: XORTX Reports Pre-Phase 3 Meeting Date with US FDA

XORTX Therapeutics

04/08/2022 12:35

Aug 4 (Reuters) - XORTX Therapeutics Inc  XRTX.V :
    * XORTX ANNOUNCES PRE-PHASE 3 MEETING DATE WITH US FOOD AND
DRUG
ADMINISTRATION
    * XORTX THERAPEUTICS - PRE-PHASE 3 MEETING REQUEST MADE TO
FDA HAS
RESULTED IN GRANT OF A VIRTUAL MEETING SCHEDULED ON SEPTEMBER
16, 2022

Source text for Eikon:  ID:nGNXbxfxjB 
Further company coverage:  XRTX.V 

 ((Reuters.Briefs@thomsonreuters.com;))